Rate control of ocular pilocarpine delivery with bispilocarpic acid diesters

被引:6
作者
Suhonen, P
Jarvinen, T
Lehmussaari, K
Reunamaki, T
Urtti, A
机构
[1] UNIV KUOPIO,DEPT PHARMACEUT CHEM,SF-70211 KUOPIO,FINLAND
[2] LEIRAS OY,SF-33721 TAMPERE,FINLAND
关键词
pilocarpine; pilocarpine prodrugs; bispilocarpic acid diesters; miotic activity; irritation; ocular drug delivery; ocular bioavailability;
D O I
10.1016/0378-5173(95)04202-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ocular delivery of pilocarpine as bispilocarpic acid diester prodrugs was studied in albino rabbits using miosis as a bioassay of pilocarpine availability in the iris. Bispilocarpic acid diester fumarate eyedrops, in a dose equivalent to 0.5% pilocarpine, were administered at pH 5.0. Bispilocarpic acid diesters increased the duration of miosis and decreased the peak miotic response of pilocarpine. The time of peak miosis was delayed from 40 min to 55-135 min with the prodrugs. The duration of action was extended with seven compounds from 3 h to 4-5 h. Plateauing responses indicating sustained release of pilocarpine from the prodrug were seen in some cases. Compared with 1% pilocarpine, the prodrugs showed either increased, decreased or equal biphasic availability of pilocarpine in the iris. Neither lipophilicity nor enzymatic lability of prodrug alone could explain the miosis profile of pilocarpine. Eye irritation increased with increasing lipophilicity of the prodrugs. It appears that the ocular bioavailability of pilocarpine and its duration of action can be improved by bispilocarpic acid diesters, but in predicting their performance both lipophilicity and prodrug cleavage rate should be taken into account.
引用
收藏
页码:85 / 94
页数:10
相关论文
共 29 条
  • [1] ARMALY MF, 1973, INVEST OPHTH VISUAL, V12, P491
  • [2] Benita S, 1984, J Microencapsul, V1, P203, DOI 10.3109/02652048409049359
  • [4] BODOR N, 1984, PHARMACEUT RES, V1, P168
  • [5] VISUAL EFFECTS OF PILOCARPINE IN GLAUCOMA - COMPARATIVE-STUDY OF ADMINISTRATION BY EYEDROPS OR BY OCULAR THERAPEUTIC SYSTEMS
    BROWN, HS
    MELTZER, G
    MERRILL, RC
    FISHER, M
    FERRE, C
    PLACE, VA
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1976, 94 (10) : 1716 - 1719
  • [6] TIMOLOL PRODRUGS - SYNTHESIS, STABILITY AND LIPOPHILICITY OF VARIOUS ALKYL, CYCLOALKYL AND AROMATIC ESTERS OF TIMOLOL
    BUNDGAARD, H
    BUUR, A
    CHANG, SC
    LEE, VHL
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 46 (1-2) : 77 - 88
  • [7] IMPROVING THE OCULAR ABSORPTION OF PHENYLEPHRINE
    CHIEN, DS
    SCHOENWALD, RD
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1986, 7 (05) : 453 - 462
  • [8] CORNEAL PERMEATION OF TOPICAL PILOCARPINE NITRATE IN RABBIT
    CHRAI, SS
    ROBINSON, JR
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1974, 77 (05) : 735 - 739
  • [9] LACRIMAL AND INSTILLED FLUID DYNAMICS IN RABBIT EYES
    CHRAI, SS
    PATTON, TF
    MEHTA, A
    ROBINSON, JR
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (07) : 1112 - 1121
  • [10] COMPARISON OF DIFFERENT MODELS FOR THE TESTING OF PILOCARPINE EYEDROPS USING CONVENTIONAL EYEDROPS AND A NOVEL DEPOT FORMULATION (NANOPARTICLES)
    DIEPOLD, R
    KREUTER, J
    HIMBER, J
    GURNY, R
    LEE, VHL
    ROBINSON, JR
    SAETTONE, MF
    SCHNAUDIGEL, OE
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1989, 227 (02) : 188 - 193